All In Biotech

NDA 021734 · Sun Pharma Canada

Loratadine

Loratadine · Oral

Discontinued

Last checked: Nov 20, 2026Latest source record: Oct 4, 2005 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2005

Oct 4, 2005

Approved uses

1

Original approval plus efficacy supplements

Registered trials

89

27 Phase 3, 6 recruiting

FAERS reports

49,834

29,895 serious, 2,936 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

No structured label for this application in openFDA. Older and discontinued products often have none.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

1 products under this application
  • LORATADINE · LORATADINE 1MG/ML · SUSPENSION, ORAL · Discontinued

Clinical trials

Interventional ClinicalTrials.gov studies with "Loratadine" as an intervention, any sponsor and status, largest first.

All 89 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • drug ineffective3,709
  • fatigue3,379
  • nausea2,814
  • dyspnoea2,540
  • headache2,517
  • diarrhoea2,470
  • off label use2,351
  • dizziness2,167
  • pain2,046
  • rash1,681
  • pruritus1,604
  • cough1,584

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
2004356
2005531
2006420
2007362
2008435
2009581
2010700
2011926
20121,188
20131,219
20141,408
20152,714
20163,655
20173,345
20183,624
20194,225
20203,755
20213,484
20223,782
20233,354
20243,615
20253,565
20262,590

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 388 on PubMed

Sponsor: Sun Pharma Canada

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.